Phase I/Phase II Study of Blinatumomab in Pediatric Patients With Relapsed/Refractory Acute Lymphoblastic Leukemia

von Stackelberg, Arend; Locatelli, Franco; Zugmaier, Gerhard; Handgretinger, Rupert; Trippett, Tanya M.; Rizzari, Carmelo; Bader, Peter; O'Brien, Maureen M.; Brethon, Benoit; Bhojwani, Deepa; Schlegel, Paul Gerhardt; Borkhardt, Arndt; Rheingold, Susan R.; Cooper, Todd Michael; Zwaan, Christian M.; Barnette, Phillip; Messina, Chiara; Michel, Gerard; DuBois, Steven G.; Hu, Kuolung; Zhu, Min; Whitlock, James A.; Gore, Lia

Phase I/Phase II Study of Blinatumomab in Pediatric Patients With Relapsed/Refractory Acute Lymphoblastic Leukemia

Autor(en):

von Stackelberg, Arend; Locatelli, Franco; Zugmaier, Gerhard; Handgretinger, Rupert; Trippett, Tanya M.; Rizzari, Carmelo; Bader, Peter; O'Brien, Maureen M.; Brethon, Benoit; Bhojwani, Deepa; Schlegel, Paul Gerhardt; Borkhardt, Arndt; Rheingold, Susan R.; Cooper, Todd Michael; Zwaan, Christian M.; Barnette, Phillip; Messina, Chiara; Michel, Gerard; DuBois, Steven G.; Hu, Kuolung; Zhu, Min; Whitlock, James A.; Gore, Lia

Tübinger Autor(en):

Handgretinger, Rupert

Erschienen in:

Journal of Clinical Oncology (2016), Bd. 34, H. 36, S. 4381-

Verlagsangabe:

Amer Soc Clinical Oncology

Sprache:

Englisch

Referenz zum Volltext:

http://dx.doi.org/10.1200/JCO.2016.67.3301

ISSN:

1527-7755